Royal Philips NV Sponsored ADR Stock News

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips, that integrates two critical PAD treatments into a single device. Procedures that previo...

Industry leaders collaborate to offer Philips clinically proven tools and resources to Aspen Dental patients, providing better care for more people CAMBRIDGE, Mass. , Oct. 30, 2024 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a partnership with Aspen Dental ®, the largest group of branded dental offices, to bring Philips Sonicare, t...

Philips' Q3 earnings showed flat sales but improved margins, driven by better productivity and pricing, despite weak performance in China. Risks include significant exposure to the Chinese market and competition, while opportunities lie in cost-cutting, AI implementation, and global growth. Due to China's economic weakness, Philips revised its sales growth guidance down to 0.5-1.5%, affecting s...

CAMBRIDGE, Mass. & WASHINGTON--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced it will accelerate the predictive health monitoring of the Rapid Analysis of Threat Exposure (RATE) algorithm to support the well-being and readiness of active-duty service personnel for the U.S. Department of Defense (DoD). Over the next four years, the Joint Program Executive Office for Chemic...

Philips faces challenges in China, but its overall fundamentals remain strong, with significant growth potential in other markets and segments like cardiovascular and ultrasound. Despite a 17% share price drop, Philips is undervalued at €24.20/share, presenting a compelling investment opportunity with an expected 11% annual EPS growth. The company shows margin improvements and resilience in var...

Koninklijke Philips N.V. (NYSE:PHG ) Q3 2024 Results Conference Call October 28, 2024 5:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Charlotte Hanneman - CFO Conference Call Participants Richard Felton - Goldman Sachs Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Lisa Clive - Bernstein Graham Doyle - UBS Hugo Solvet - E...

American depositary receipts (ADRs) of Koninklijke Philips (PHG) are tumbling more than 15% in premarket trading Monday after the Dutch conglomerate cut its 2024 sales outlook amid a "significant deterioration" in Chinese demand.

It's a reminder of how sluggish demand in the world's second-largest economy could cause problems for the likes of Starbucks and Marriott.